Dr. Lynn Allen-Hoffmann, Founder and former CEO of Stratatech Corporation, now a Mallinckrodt company; current Senior Vice President of Regenerative Medicine at Mallinckrodt; and Professor of Pathology and Laboratory Medicine at University of Wisconsin-Madison, will receive the Hector F. DeLuca Scientific Achievement Award, celebrating her exceptional success in developing regenerative medicine products that have the […]
The “Drones & Cones” event at URP highlighted how drone technology can enhance entrepreneurial efforts.
Stemina Biomarker Discovery Inc. announced that Dr. Heiner Dreismann, former head of Roche Molecular Diagnostics, has joined the Board of Directors to bring his extensive experience in commercialization strategy to the company as it prepares to go to market with its autism diagnostic test panel.
DotCom Therapy, a Madison, WI-based startup that has developed software allowing the dozens of therapists it employs to provide remote speech therapy services to schoolchildren, captured first place in one of Wisconsin’s more closely watched pitch competitions on Monday.
DotCom Therapy — a company that provides speech and language therapy to patients via live videoconferencing, and that just moved to University Research Parkl this spring — won the Pressure Chamber pitch competition Monday at the Overture Center.
FluGen, an early-stage company, located at URP, developing vaccine candidates designed to protect against multiple types of influenza, has raised $5.5 million in debt financing.
Invenra, a Madison startup involved in the race to find drugs that will beat cancer, says it is teaming with Merck, one of the world’s leading pharmaceutical companies.
Cellular Dynamics International, the stem cell company founded by UW-Madison stem cell pioneer James Thomson, is backing off on moving its headquarters to Verona and will stay in Madison, at least for now, as it prepares to push forward with its first potential stem cell-based treatment.
Exact Sciences said a major study on its second product in the pipeline — a test for lung cancer — will likely begin in early 2018.
B. Lynn Allen-Hoffman and Stratatech are full of big ideas at University Research Park.